Pricing Log in Create free account

Conexeu Sciences Inc. (CNXU) vs Telomir Pharmaceuticals, Inc. (TELO)

Conexeu Sciences Inc. and Telomir Pharmaceuticals, Inc. are both Biotechnology companies. Conexeu Sciences Inc. is the larger, with a market value of $65.4M against $57.5M — 1.1× the size. Across the 10 metrics below, Telomir Pharmaceuticals, Inc. leads on 6 and Conexeu Sciences Inc. on 4.

Valuation

Metric CNXU TELO Biotechnology median
P/E n/m n/m 10.26
P/S n/m n/m 9.18
P/B 9.64 9.43 2.05
Price to free cash flow n/m n/m 24.81
EV/EBITDA n/m n/m 0.65
EV/Sales n/m n/m 8.98
Earnings yield (29.81%) (116.67%) (34.89%)
Free cash flow yield (18.82%) (10.36%) (24.52%)

Profitability

Metric CNXU TELO Biotechnology median
Gross margin — — 65.16%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity (458.40%) (1,885.50%) (50.12%)
Return on assets (354.37%) (1,678.31%) (45.60%)
Return on invested capital (234.60%) 0.00% 0.00%

Growth

Metric CNXU TELO Biotechnology median
Revenue growth (TTM) — — 6.26%
EPS growth (last fiscal year) (342.80%) 41.07% 29.88%
Revenue growth, 5-year CAGR — — 9.75%
Net income growth, 5-year CAGR — — 0.00%

Health

Metric CNXU TELO Biotechnology median
Debt to equity 0.00 0.03 0.00
Current ratio 5.31 16.14 4.89
Net debt to EBITDA 1.23 0.69 1.01

Dividend

Metric CNXU TELO Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric CNXU TELO Biotechnology median
Market cap 65.36m 57.48m 172.11m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack